21 results on '"Khan, Haroon"'
Search Results
2. Advances and challenges in cancer treatment and nutraceutical prevention: the possible role of dietary phenols in BRCA regulation
- Author
-
Khan, Haroon, Labanca, Fabiana, Ullah, Hammad, Hussain, Yaseen, Tzvetkov, Nikolay T., Akkol, Esra Küpeli, and Milella, Luigi
- Published
- 2022
- Full Text
- View/download PDF
3. Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway.
- Author
-
Iranpanah, Amin, Majnooni, Mohammad Bagher, Biganeh, Hossein, Amirian, Roshanak, Rastegari‐Pouyani, Mohsen, Filosa, Rosanna, Cheang, Wai San, Fakhri, Sajad, and Khan, Haroon
- Abstract
Recently, malignant neoplasms have growingly caused human morbidity and mortality. Head and neck cancer (HNC) constitutes a substantial group of malignancies occurring in various anatomical regions of the head and neck, including lips, mouth, throat, larynx, nose, sinuses, oropharynx, hypopharynx, nasopharynx, and salivary glands. The present study addresses the phosphoinositide 3‐kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway as a possible therapeutic target in cancer therapy. Finding new multitargeting agents capable of modulating PI3K/Akt/mTOR and cross‐linked mediators could be viewed as an effective strategy in combating HNC. Recent studies have introduced phytochemicals as multitargeting agents and rich sources for finding and developing new therapeutic agents. Phytochemicals have exhibited immense anticancer effects, including targeting different stages of HNC through the modulation of several signaling pathways. Moreover, phenolic/polyphenolic compounds, alkaloids, terpenes/terpenoids, and other secondary metabolites have demonstrated promising anticancer activities because of their diverse pharmacological and biological properties like antiproliferative, antineoplastic, antioxidant, and anti‐inflammatory activities. The current review is mainly focused on new therapeutic strategies for HNC passing through the PI3K/Akt/mTOR pathway as new strategies in combating HNC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer.
- Author
-
Sharma, Aditi, Sharma, Lalit, Nandy, Shouvik Kumar, Payal, Nazrana, Yadav, Shivam, Vargas-De-La-Cruz, Celia, Anwer, Md. Khalid, Khan, Haroon, Behl, Tapan, and Bungau, Simona Gabriela
- Subjects
MOLECULAR oncology ,DNA ,CHROMOSOME duplication ,COMBINATION drug therapy ,CARCINOGENESIS ,DRUG resistance in cancer cells - Abstract
Due to genetic changes in DNA (deoxyribonucleic acid) sequences, cancer continues to be the second most prevalent cause of death. The traditional target-directed approach, which is confronted with the importance of target function in healthy cells, is one of the most significant challenges in anticancer research. Another problem with cancer cells is that they experience various mutations, changes in gene duplication, and chromosomal abnormalities, all of which have a direct influence on the potency of anticancer drugs at different developmental stages. All of these factors combine to make cancer medication development difficult, with low clinical licensure success rates when compared to other therapy categories. The current review focuses on the pathophysiology and molecular aspects of common cancer types. Currently, the available chemotherapeutic drugs, also known as combination chemotherapy, are associated with numerous adverse effects, resulting in the search for herbal-based alternatives that attenuate resistance due to cancer therapy and exert chemo-protective actions. To provide new insights, this review updated the list of key compounds that may enhance the efficacy of cancer treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Antioxidant and anticancer potentials of edible flowers: where do we stand?
- Author
-
Fakhri, Sajad, Tomas, Merve, Capanoglu, Esra, Hussain, Yaseen, Abbaszadeh, Fatemeh, Lu, Baiyi, Hu, Xiaolan, Wu, Jianlin, Zou, Liang, Smeriglio, Antonella, Simal-Gandara, Jesus, Cao, Hui, Xiao, Jianbo, and Khan, Haroon
- Abstract
Edible flowers are attracting special therapeutic attention and their administration is on the rise. Edible flowers play pivotal modulatory roles on oxidative stress and related interconnected apoptotic/inflammatory pathways toward the treatment of cancer. In this review, we highlighted the phytochemical content and therapeutic applications of edible flowers, as well as their modulatory potential on the oxidative stress pathways and apoptotic/inflammatory mediators, resulting in anticancer effects. Edible flowers are promising sources of phytochemicals (e.g., phenolic compounds, carotenoids, terpenoids) with several therapeutic effects. They possess anti-inflammatory, anti-diabetic, anti-microbial, anti-depressant, anxiolytic, anti-obesity, cardioprotective, and neuroprotective effects. Edible flowers potentially modulate oxidative stress by targeting erythroid nuclear transcription factor-2/extracellular signal-regulated kinase/mitogen-activated protein kinase (Nrf2/ERK/MAPK), reactive oxygen species (ROS), nitric oxide (NO), malondialdehyde (MDA) and antioxidant response elements (AREs). As the interconnected pathways to oxidative stress, inflammatory mediators, including tumor necrosis factor (TNF)-α, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), interleukins (ILs) as well as apoptotic pathways such as Bcl-2-associated X protein (Bax), Bcl-2, caspase and cytochrome C are critical targets of edible flowers in combating cancer. In this regard, edible flowers could play promising anticancer effects by targeting oxidative stress and downstream dysregulated pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Antioxidant and anticancer potentials of edible flowers: where do we stand?
- Author
-
Fakhri, Sajad, Tomas, Merve, Capanoglu, Esra, Hussain, Yaseen, Abbaszadeh, Fatemeh, Lu, Baiyi, and Khan, Haroon
- Subjects
signaling pathway ,MEDIATED PHOTODYNAMIC THERAPY ,EXTRACT INDUCES APOPTOSIS ,INDUCED OXIDATIVE STRESS ,BREAST-CANCER CELLS ,Apoptosis ,therapeutic targets ,ROSMARINUS-OFFICINALIS L ,CELL-CYCLE ARREST ,EHRLICHS ASCITES-CARCINOMA ,ENDOPLASMIC-RETICULUM STRESS ,edible flowers ,inflammation ,cancer ,oxidative stress ,RADICAL SCAVENGING ACTIVITY ,pharmacology ,IN-VITRO ANTIOXIDANT - Abstract
Edible flowers are attracting special therapeutic attention and their administration is on the rise. Edible flowers play pivotal modulatory roles on oxidative stress and related interconnected apoptotic/inflammatory pathways toward the treatment of cancer. In this review, we highlighted the phytochemical content and therapeutic applications of edible flowers, as well as their modulatory potential on the oxidative stress pathways and apoptotic/inflammatory mediators, resulting in anticancer effects. Edible flowers are promising sources of phytochemicals (e.g., phenolic compounds, carotenoids, terpenoids) with several therapeutic effects. They possess anti-inflammatory, anti-diabetic, anti-microbial, anti-depressant, anxiolytic, anti-obesity, cardioprotective, and neuroprotective effects. Edible flowers potentially modulate oxidative stress by targeting erythroid nuclear transcription factor-2/extracellular signal-regulated kinase/mitogen-activated protein kinase (Nrf2/ERK/MAPK), reactive oxygen species (ROS), nitric oxide (NO), malondialdehyde (MDA) and antioxidant response elements (AREs). As the interconnected pathways to oxidative stress, inflammatory mediators, including tumor necrosis factor (TNF)-alpha, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B), interleukins (ILs) as well as apoptotic pathways such as Bcl-2-associated X protein (Bax), Bcl-2, caspase and cytochrome C are critical targets of edible flowers in combating cancer. In this regard, edible flowers could play promising anticancer effects by targeting oxidative stress and downstream dysregulated pathways.
- Published
- 2021
7. Prospective Role of Bioactive Molecules and Exosomes in the Therapeutic Potential of Camel Milk against Human Diseases: An Updated Perspective.
- Author
-
Khan, Farheen Badrealam, Ansari, Mohammad Azam, Uddin, Shahab, Palakott, Abdul Rasheed, Anwar, Irfa, Almatroudi, Ahmad, Alomary, Mohammad N., Alrumaihi, Faris, Aba Alkhayl, Faris F., Alghamdi, Saad, Muhammad, Khalid, Huang, Chih-Yang, Daddam, Jayasimha Rayalu, Khan, Haroon, Maqsood, Sajid, and Ayoub, Mohammed Akli
- Subjects
CAMEL milk ,BREAST milk ,EXOSOMES ,GROWTH factors ,MOLECULES - Abstract
Camel milk (CM) constitutes an important dietary source in the hot and arid regions of the world. CM is a colloidal mixture of nutritional components (proteins, carbohydrates, lipids, vitamins, and minerals) and non-nutritional components (hormones, growth factors, cytokines, immunoglobulins, and exosomes). Although the majority of previous research has been focused on the nutritional components of CM; there has been immense interest in the non-nutritional components in the recent past. Reckoning with these, in this review, we have provided a glimpse of the recent trends in CM research endeavors and attempted to provide our perspective on the therapeutic efficacy of the nutritional and non-nutritional components of CM. Interestingly, with concerted efforts from the research fraternities, convincing evidence for the better understanding of the claimed traditional health benefits of CM can be foreseen with great enthusiasm and is indeed eagerly anticipated. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. The Regulation of Endoplasmic Reticulum Stress in Cancer: Special Focuses on Luteolin Patents.
- Author
-
Mohi-ud-din, Roohi, Mir, Reyaz Hassan, Wani, Taha Umair, Alsharif, Khalaf F., Alam, Waqas, Albrakati, Ashraf, Saso, Luciano, and Khan, Haroon
- Subjects
LUTEOLIN ,ENDOPLASMIC reticulum ,UNFOLDED protein response ,PATENT databases ,FLAVONOIDS ,PATENTS - Abstract
Cancer is a major health problem across the globe, and is expeditiously growing at a faster rate worldwide. The endoplasmic reticulum (ER) is a membranous cell organelle having inextricable links in cellular homeostasis. Altering ER homeostasis initiates various signaling events known as the unfolded protein response (UPR). The basic purpose of the UPR is to reinstate the homeostasis; however, a continuous UPR can stimulate pathways of cell death, such as apoptosis. As a result, there is great perturbation to target particular signaling pathways of ER stress. Flavonoids have gained significant interest as a potential anticancer agent because of their considerable role in causing cytotoxicity of the cancerous cells. Luteolin, a flavonoid isolated from natural products, is a promising phytochemical used in the treatment of cancer. The current study is designed to review the different endoplasmic reticulum stress pathways involved in the cancer, mechanistic insights of luteolin as an anticancer agent in modulating ER stress, and the available luteolin patent formulations were also highlighted. The patents were selected on the basis of pre-clinical and/or clinical trials, and established antitumor effects using patent databases of FPO IP and Espacenet. The patented formulation of luteolin studied so far has shown promising anticancer potential against different cancer cell lines. However, further research is still required to determine the molecular targets of such bioactive molecules so that they can be used as anticancer drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Targeting lactate metabolism and glycolytic pathways in the tumor microenvironment by natural products: A promising strategy in combating cancer.
- Author
-
Kooshki, Leila, Mahdavi, Parisa, Fakhri, Sajad, Akkol, Esra Küpeli, and Khan, Haroon
- Subjects
MONOCARBOXYLATE transporters ,GLYCOLYSIS ,LACTATES ,TUMOR microenvironment ,NATURAL products ,METABOLISM ,LACTATION ,ALTERNATIVE treatment for cancer - Abstract
Anticancer drugs are not purely effective because of their toxicity, side effects, high cost, inaccessibility, and associated resistance. On the other hand, cancer is a complex public health problem that could intelligently adopt different signaling pathways and alter the body's metabolism to escape from the immune system. One of the cancer strategies to metastasize is modifying pH in the tumor microenvironment, ranging between 6.5 and 6.9. As a powerful determiner, lactate is responsible for this acidosis. It is involved in immune stimulation, including innate and adaptive immunity, apoptotic‐related factors (Bax/Bcl‐2, caspase), and glycolysis pathways (e.g., GLUT‐1, PKM2, PFK, HK2, MCT‐1, and LDH). Lactate metabolism, in turn, is interconnected with several dysregulated signaling mediators, including PI3K/Akt/mTOR, AMPK, NF‐κB, Nrf2, JAK/STAT, and HIF‐1α. Because of lactate's emerging and critical role, targeting lactate production and its transporters is important for preventing and managing tumorigenesis. Hence, exploring and developing novel promising anticancer agents to minimize human cancers is urgent. Based on numerous studies, natural secondary metabolites as multi‐target alternative compounds with health‐promoting properties possess more high effectiveness and low side effects than conventional agents. Besides, the mechanism of multi‐targeted natural sources is related to lactate production and cancer‐associated cross‐talked factors. This review focuses on targeting the lactate metabolism/transporters, and lactate‐associated mediators, including glycolytic pathways. Besides, interconnected mediators to lactate metabolism are also targeted by natural products. Accordingly, plant‐derived secondary metabolites are introduced as alternative therapies in combating cancer through modulating lactate metabolism and glycolytic pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects.
- Author
-
Hussain, Yaseen, Islam, Lubna, Khan, Haroon, Filosa, Rosanna, Aschner, Michael, and Javed, Saba
- Abstract
The efficacy of chemotherapy in cancer therapy is limited due to resistance, treatment selectivity, and severe adverse effects. Immunotherapy, chemotherapy, targeted therapy, radiation, and surgery are the most common therapeutic strategies for treatment, with chemotherapy being the most successful. Nonetheless, these treatments exhibit poor effectiveness due to toxicity and resistance. Therefore, combination therapies of natural products may be used as an effective and novel strategy to overcome such barriers. Cisplatin is a platinum‐based chemotherapy agent, and when administered alone, it can lead to severe adverse effects and resistance mechanism resulting in therapeutic failure. Curcumin is a polyphenolic compound extracted from turmeric (Curcuma longa) exhibiting anticancer potential with minimal adverse effects. The combination therapy of curcumin and cisplatin is a novel strategy to mitigate/attenuate cisplatin‐related adverse effects and improve the barrier of resistance reducing unwanted effects. However, there are uncertainties on the efficacy of curcumin, and more in depth and high‐quality studies are needed. This review aims to explain the adverse effects related to individual cisplatin delivery, the positive outcome of individual curcumin delivery, and the combination therapy of curcumin and cisplatin from nano platform as a novel strategy for cancer therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Glyco-nanoparticles: New drug delivery systems in cancer therapy.
- Author
-
Khan, Haroon, Mirzaei, Hamid Reza, Amiri, Atefeh, Kupeli Akkol, Esra, Ashhad Halimi, Syed Muhammad, and Mirzaei, Hamed
- Subjects
- *
DRUG delivery systems , *CANCER treatment , *QUANTUM dots , *ANTINEOPLASTIC agents , *LIPOSOMES - Abstract
Cancer is known as one of the most common diseases that are associated with high mobility and mortality in the world. Despite several efforts, current cancer treatment modalities often are highly toxic and lack efficacy and specificity. However, the application of nanotechnology has led to the development of effective nanosized drug delivery systems which are highly selective for tumors and allow a slow release of active anticancer agents. Different Nanoparticles (NPs) such as the silicon-based nano-materials, polymers, liposomes and metal NPs have been designed to deliver anti-cancer drugs to tumor sites. Among different drug delivery systems, carbohydrate-functionalized nanomaterials, specially based on their multi-valent binding capacities and desirable bio-compatibility, have attracted considerable attention as an excellent candidate for controlled release of therapeutic agents. In addition, these carbohydrate functionalized nano-carriers are more compatible with construction of the intracellular delivery platforms like the carbohydrate-modified metal NPs, quantum dots, and magnetic nano-materials. In this review, we discuss recent research in the field of multifunctional glycol-nanoparticles (GNPs) intended for cancer drug delivery applications. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials
- Author
-
Nabavi, Seyed Fazel, Atanasov, Atanas G., Khan, Haroon, Barreca, Davide, Trombetta, Domenico, Testai, Lara, Sureda, Antoni, Tejada, Silvia, Vacca, Rosa Anna, Pittalà, Valeria, Gulei, Diana, Berindan-Neagoe, Ioana, Shirooie, Samira, and Nabavi, Seyed Mohammad
- Subjects
0301 basic medicine ,Proteasome Endopeptidase Complex ,Cancer Research ,Anti-cancer agents, Cancer, Enzymatic modulator, Oncoproteins, Polyphenols, Proteasome, Ubiquitin, Ubiquitin-proteasome pathway, Oncology, Cancer Research ,Oncoproteins ,Anti-cancer agents ,Antineoplastic Agents ,Cancer ,Enzymatic modulator ,Polyphenols ,Proteasome ,Ubiquitin ,Ubiquitin-proteasome pathway ,Oncology ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,law ,Neoplasms ,medicine ,Humans ,Molecular Targeted Therapy ,Clinical Trials as Topic ,biology ,Intracellular protein ,food and beverages ,medicine.disease ,Cell biology ,030104 developmental biology ,Proteasome activity ,Polyphenol ,030220 oncology & carcinogenesis ,biology.protein ,Suppressor ,Cancer development ,Signal Transduction - Abstract
The ubiquitin-proteasome pathway (UPP) is the main non-lysosomal proteolytic system responsible for degradation of most intracellular proteins, specifically damaged and regulatory proteins. The UPP is implicated in all aspects of the cellular metabolic networks including physiological or pathological conditions. Alterations in the components of the UPP can lead to stabilization of oncoproteins or augmented degradation of tumour suppressor favouring cancer appearance and progression. Polyphenols are natural compounds that can modulate proteasome activity or the expression of proteasome subunits. All together and due to the pleiotropic functions of UPP, there is a great interest in this proteasome system as a promising therapeutic target for the development of novel anti-cancer drugs. In the present review, the main features of the UPP and its implication in cancer development and progression are described, highlighting the importance of bioactive polyphenols that target the UPP as potential anti-cancer agents.
- Published
- 2018
13. MicroRNAs regulating SOX2 in cancer progression and therapy response.
- Author
-
Mirzaei, Sepideh, Saebfar, Hamidreza, Gholami, Mohammad Hossein, Hashemi, Farid, Zarrabi, Ali, Zabolian, Amirhossein, Entezari, Maliheh, Hushmandi, Kiavash, Samarghandian, Saeed, Aref, Amir Reza, Ashrafizadeh, Milad, and Khan, Haroon
- Subjects
MICRORNA ,CANCER invasiveness ,CANCER chemotherapy ,RNA regulation ,NON-coding RNA - Abstract
The proliferation, metastasis and therapy response of tumour cells are tightly regulated by interaction among various signalling networks. The microRNAs (miRNAs) can bind to 3′-UTR of mRNA and down-regulate expression of target gene. The miRNAs target various molecular pathways in regulating biological events such as apoptosis, differentiation, angiogenesis and migration. The aberrant expression of miRNAs occurs in cancers and they have both tumour-suppressor and tumour-promoting functions. On the contrary, SOX proteins are capable of binding to DNA and regulating gene expression. SOX2 is a well-known member of SOX family that its overexpression in different cancers to ensure progression and stemness. The present review focuses on modulatory impact of miRNAs on SOX2 in affecting growth, migration and therapy response of cancers. The lncRNAs and circRNAs can function as upstream mediators of miRNA/SOX2 axis in cancers. In addition, NF-κB, TNF-α and SOX17 are among other molecular pathways regulating miRNA/SOX2 axis in cancer. Noteworthy, anti-cancer compounds including bufalin and ovatodiolide are suggested to regulate miRNA/SOX2 axis in cancers. The translation of current findings to clinical course can pave the way to effective treatment of cancer patients and improve their prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
14. Targeting NF-κB signaling pathway in cancer by dietary polyphenols.
- Author
-
Khan, Haroon, Ullah, Hammad, Castilho, Paula Cristina Machado Ferreira, Gomila, Antoni Sureda, D'Onofrio, Grazia, Filosa, Rosanna, Wang, Fang, Nabavi, Seyed Mohammad, Daglia, Maria, Silva, Ana Sanches, Rengasamy, Kannan R. R., Ou, Juanying, Zou, Xiaobo, Xiao, Jianbo, and Cao, Hui
- Subjects
- *
POLYPHENOLS , *TRANSCRIPTION factors , *CANCER prevention , *CELL proliferation , *DRUG resistance , *APOPTOSIS , *CELLULAR signal transduction , *TUMORS , *DNA-binding proteins , *CHEMICAL inhibitors - Abstract
Being a transcription factor, NF-κB regulates gene expressions involving cell survival and proliferation, drug resistance, metastasis, and angiogenesis. The activation of NF-κB plays a central role in the development of inflammation and cancer. Thus, the down-regulation of NF-κB may be an exciting target in prevention and treatment of cancer. NF-κB could act as a tumor activator or tumor suppressant decided by the site of action (organ). Polyphenols are widely distributed in plant species, consumption of which have been documented to negatively regulate the NF-κB signaling pathway. They depress the phosphorylation of kinases, inhibit NF-κB translocate into the nucleus as well as interfere interactions between NF-κB and DNA. Through inhibition of NF-κB, polyphenols downregulate inflammatory cascade, induce apoptosis and decrease cell proliferation and metastasis. This review highlights the anticancer effects of polyphenols on the basis of NF-κB signaling pathway regulation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
15. Bcl-2 Modulation in p53 Signaling Pathway by Flavonoids: A Potential Strategy towards the Treatment of Cancer.
- Author
-
Rahman, Noor, Khan, Haroon, Zia, Asad, Khan, Asifullah, Fakhri, Sajad, Aschner, Michael, Gul, Karim, and Saso, Luciano
- Subjects
- *
CELLULAR signal transduction , *FLAVONOIDS , *CAUSES of death , *CANCER treatment , *ETIOLOGY of cancer , *METABOLITES - Abstract
Cancer is a major cause of death, affecting human life in both developed and developing countries. Numerous antitumor agents exist but their toxicity and low efficacy limits their utility. Furthermore, the complex pathophysiological mechanisms of cancer, serious side effects and poor prognosis restrict the administration of available cancer therapies. Thus, developing novel therapeutic agents are required towards a simultaneous targeting of major dysregulated signaling mediators in cancer etiology, while possessing lower side effects. In this line, the plant kingdom is introduced as a rich source of active phytochemicals. The secondary metabolites produced by plants could potentially regulate several dysregulated pathways in cancer. Among the secondary metabolites, flavonoids are hopeful phytochemicals with established biological activities and minimal side effects. Flavonoids inhibit B-cell lymphoma 2 (Bcl-2) via the p53 signaling pathway, which is a significant apoptotic target in many cancer types, hence suppressing a major dysregulated pathway in cancer. To date, there have been no studies reported which extensively highlight the role of flavonoids and especially the different classes of flavonoids in the modulation of Bcl-2 in the P53 signaling pathway. Herein, we discuss the modulation of Bcl-2 in the p53 signaling pathway by different classes of flavonoids and highlight different mechanisms through which this modulation can occur. This study will provide a rationale for the use of flavonoids against different cancers paving a new mechanistic-based approach to cancer therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. MicroRNA targeting by quercetin in cancer treatment and chemoprotection.
- Author
-
Kim, Doo Hwan, Khan, Haroon, Ullah, Hammad, Hassan, Sherif T.S., Šmejkal, Karel, Efferth, Thomas, Mahomoodally, Mohamad Fawzi, Xu, Suowen, Habtemariam, Solomon, Filosa, Rosanna, Lagoa, Ricardo, and Rengasamy, Kannan RR
- Subjects
- *
MICRORNA , *QUERCETIN , *CANCER treatment , *PHYTOCHEMICALS , *NATURAL products , *CANCER invasiveness - Abstract
A growing number of evidences from clinical and preclinical studies have shown that dysregulation of microRNA (miRNA) function contributes to the progression of cancer and thus miRNA can be an effective target in therapy. Dietary phytochemicals, such as quercetin, are natural products that have potential anti-cancer properties due to their proven antioxidant, anti-inflammatory, and anti-proliferative effects. Available experimental studies indicate that quercetin could modulate multiple cancer-relevant miRNAs including let-7, miR-21, miR-146a and miR-155, thereby inhibiting cancer initiation and development. This paper reviews the data supporting the use of quercetin for miRNA-mediated chemopreventive and therapeutic strategies in various cancers, with the aim to comprehensively understand its health‐promoting benefits and pharmacological potential. Integration of technology platforms for miRNAs biomarker and drug discovery is also presented. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
17. Interplay between SOX9 transcription factor and microRNAs in cancer.
- Author
-
Ashrafizadeh, Milad, Zarrabi, Ali, Orouei, Sima, Zabolian, Amirhossein, Saleki, Hossein, Azami, Negar, Bejandi, Atefe Kazemzade, Mirzaei, Sepideh, Janaghard, Milad Nemati, Hushmandi, Kiavash, Nabavi, Noushin, Baradaran, Behzad, Kumar, Alan Prem, Makvandi, Pooyan, Samarghandian, Saeed, Khan, Haroon, and Hamblin, Michael R.
- Subjects
- *
SOX transcription factors , *TRANSCRIPTION factors , *NON-coding RNA , *MICRORNA , *LINCRNA , *CANCER invasiveness - Abstract
SOX transcription factors are critical regulators of development, homeostasis and disease progression and their dysregulation is a common finding in various cancers. SOX9 belongs to SOXE family located on chromosome 17. MicroRNAs (miRNAs) possess the capacity of regulating different transcription factors in cancer cells by binding to 3′-UTR. Since miRNAs can affect differentiation, migration, proliferation and other physiological mechanisms, disturbances in their expression have been associated with cancer development. In this review, we evaluate the relationship between miRNAs and SOX9 in different cancers to reveal how this interaction can affect proliferation, metastasis and therapy response of cancer cells. The tumor-suppressor miRNAs can decrease the expression of SOX9 by binding to the 3′-UTR of mRNAs. Furthermore, the expression of downstream targets of SOX9, such as c-Myc , Wnt , PI3K/Akt can be affected by miRNAs. It is noteworthy that other non-coding RNAs including lncRNAs and circRNAs regulate miRNA/SOX9 expression to promote/inhibit cancer progression and malignancy. The pre-clinical findings can be applied as biomarkers for diagnosis and prognosis of cancer patients. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. Ginsenosides in cancer: Targeting cell cycle arrest and apoptosis.
- Author
-
Shah, Muhammad Ajmal, Abuzar, Syed Muhammad, Ilyas, Kainat, Qadees, Irtaza, Bilal, Momna, Yousaf, Rimsha, Kassim, Roaa Mohammed Tahir, Rasul, Azhar, Saleem, Uzma, Alves, Maria Silvana, Khan, Haroon, Blundell, Renald, and Jeandet, Philippe
- Subjects
- *
GINSENOSIDES , *WNT signal transduction , *CELL cycle regulation , *CELL cycle , *CANCER cells , *CATENINS , *APOPTOSIS , *GENE expression - Abstract
Despite the existence of extensive clinical research and novel therapeutic treatments, cancer remains undefeated and the significant cause of death worldwide. Cancer is a disease in which growth of cells goes out of control, being also able to invade other parts of the body. Cellular division is strictly controlled by multiple checkpoints like G1/S and G2/M which, when dysregulated, lead to uncontrollable cell division. The current remedies which are being utilized to combat cancer are monoclonal antibodies, chemotherapy, cryoablation, and bone marrow transplant etc. and these have also been greatly disheartening because of their serious adverse effects like hypotension, neuropathy, necrosis, leukemia relapse and many more. Bioactive compounds derived from natural products have marked the history of the development of novel drug therapies against cancer among which ginsenosides have no peer as they target several signaling pathways, which when abnormally regulated, lead to cancer. Substantial research has reported that ginsenosides like Rb1, Rb2, Rb3, Rc, Rd, Rg3, Rh2 etc. can prevent and treat cancer by targeting different pathways and molecules by induction of autophagy, neutralizing ROS, induction of cancerous cell death by controlling the p53 pathway, modulation of miRNAs by decreasing Smad2 expression, regulating Bcl-2 expression by normalizing the NF-Kb pathway, inhibition of inflammatory pathways by decreasing the production of cytokines like IL-8, causing cell cycle arrest by restricting cyclin E1 and CDC2, and induction of apoptosis during malignancy by decreasing β-catenin levels etc. In this review, we have analyzed the anti-cancer therapeutic potential of various ginsenoside compounds in order to consider their possible use in new strategies in the fight against cancer. [Display omitted] • Use of ginsenosides as a possible a new strategy in fighting cancer. • Ginsenosides display anti-cancer activity through regulation of cell cycle and apoptosis. • New dimension of the antitumor effects of ginsenosides in various cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. A renewed concept on the MAPK signaling pathway in cancers: Polyphenols as a choice of therapeutics.
- Author
-
Anjum, Juhaer, Mitra, Saikat, Das, Rajib, Alam, Roksana, Mojumder, Anik, Emran, Talha Bin, Islam, Fahadul, Rauf, Abdur, Hossain, Md. Jamal, Aljohani, Abdullah S.M., Abdulmonem, Waleed Al, Alsharif, Khalaf F., Alzahrani, Khalid J., and Khan, Haroon
- Subjects
- *
MITOGEN-activated protein kinases , *CELLULAR signal transduction , *POLYPHENOLS , *CANCER cell growth , *CARCINOGENESIS - Abstract
Abnormalities in the mitogen-activated protein kinase (MAPK) signaling pathway are a key contributor to the carcinogenesis process and have therefore been implicated in several aspects of tumorigenesis, including cell differentiation, proliferation, invasion, angiogenesis, apoptosis, and metastasis. This pathway offers multiple molecular targets that may be modulated for anticancer activity and is of great interest for several malignancies. Polyphenols from various dietary sources have been observed to interfere with certain aspects of this pathway and consequently play a substantial role in the development and progression of cancer by suppressing cell growth, inactivating carcinogens, blocking angiogenesis, causing cell death, and changing immunity. A good number of polyphenolic compounds have shown promising outcomes in numerous pieces of research and are currently being investigated clinically to treat cancer patients. The current study concentrates on the role of the MAPK pathway in the development and metastasis of cancer, with particular emphasis on dietary polyphenolic compounds that influence the different MAPK sub-pathways to obtain an anticancer effect. This study aims to convey an overview of the various aspects of the MAPK pathway in cancer development and invasion, as well as a review of the advances achieved in the development of polyphenols to modulate the MAPK signaling pathway for better treatment of cancer. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Anticancer effects of acteoside: Mechanistic insights and therapeutic status.
- Author
-
Khan, Rasel Ahmed, Hossain, Rajib, Roy, Pranta, Jain, Divya, Mohammad Saikat, Abu Saim, Roy Shuvo, Anik Prasad, Akram, Muhammad, Elbossaty, Walaa Fikry, Khan, Ishaq N., Painuli, Sakshi, Semwal, Prabhakar, Rauf, Abdur, Islam, Muhammad Torequl, and Khan, Haroon
- Subjects
- *
ANTINEOPLASTIC agents , *SEARCH engines , *CULTIVARS , *PUBLIC health , *CANCER cells , *ANIMAL models in research - Abstract
Cancer, the uncontrolled proliferation and metastasis of abnormal cells, is a major public health issue worldwide. To date, several natural compounds have been reported with their efficacy in the treatment of different types of cancer. Chemotherapeutic agents are used in cancer treatment and prevention, among other aspects. Acteoside is a phenylethanoid glycoside, first isolated from Verbascum sinuatum , which has demonstrated multiple effects, including antioxidant, anti-epileptic, neuroprotective, anti-inflammatory, antifungal, antihypertensive, and anti-leishmanial properties. This review gathered, analyzed, and summarized the literature on acteoside and its anticancer properties. All the available information about this compound and its role in different types of cancer was collected using different scientific search engines, including PubMed, Scopus, Springer Link, Wiley Online, Web of Science, Scifinder, ScienceDirect, and Google Scholar. Acteoside is found in a variety of plants and has been shown to have anticancer activity in many experimental models through oxidative stress, apoptosis, anti-angiogenesis, anti-invasion, anti-metastasis, synergism with other agents, and anti-proliferative effects through modulation of several pathways. In conclusion, acteoside exhibited potent anticancer activity against different cancer cell lines through modulating several cancer signaling pathways in different non- and pre-clinical experimental models and thus could be a strong candidate for further clinical studies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
21. Plant-based vaccines and cancer therapy: Where are we now and where are we going?
- Author
-
Rahimian, Neda, Miraei, Hamid Reza, Amiri, Atefeh, Ebrahimi, Mohammad Saeid, Nahand, Javid Sadri, Tarrahimofrad, Hossein, Hamblin, Michael R., Khan, Haroon, and Mirzaei, Hamed
- Subjects
- *
CANCER vaccines , *CANCER treatment , *VACCINE effectiveness , *RECOMBINANT proteins , *VACCINE development - Abstract
Therapeutic vaccines are an effective approach in cancer therapy for treating the disease at later stages. The Food and Drug Administration (FDA) recently approved the first therapeutic cancer vaccine, and further studies are ongoing in clinical trials. These are expected to result in the future development of vaccines with relatively improved efficacy. Several vaccination approaches are being studied in pre-clinical and clinical trials, including the generation of anti-cancer vaccines by plant expression systems.This approach has advantages, such as high safety and low costs, especially for the synthesis of recombinant proteins. Nevertheless, the development of anti-cancer vaccines in plants is faced with some technical obstacles.Herein, we summarize some vaccines that have been used in cancer therapy, with an emphasis on plant-based vaccines. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.